Results 101 to 110 of about 27,519 (222)

IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y.

PLoS ONE
BackgroundIgG subclass levels in hemochromatosis are incompletely characterized.MethodsWe characterized IgG subclass levels of referred hemochromatosis probands with HFE p.C282Y/p.C282Y (rs1800562) and human leukocyte antigen (HLA)-A and -B typing ...
James C Barton, J Clayborn Barton, Luigi F Bertoli, Ronald T Acton   +3 more
doaj   +1 more source

A CASE OF SECONDARY HEMOCHROMATOSIS [PDF]

, 1973
Article信州医学雑誌 21(4): 491-498(1973)journal ...
清水, 浩安, 草間, 昌三, 小野, 隆彦, 戸塚, 忠政, 野溝, 孝平, 藤森, 勲, 藤井, 忠重, 半田, 健次郎, 立岩, 孝之, 野口, 修, 津田, 四朗, 望月, 一郎   +11 more
core  

Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin

Haematologica, 2000
Juvenile hemochromatosis is a rare genetic disorder that causes iron overload. Clinical complications, which include liver cirrhosis, heart failure, hypogonadotropic hypogonadism and diabetes, appear earlier and are more severe than in HFE-related ...
M De Gobbi, P Pasquero, F Brunello, P Paccotti, U Mazza, C Camaschella   +5 more
doaj  

Dietary advice in HFE-hemochromatosis [PDF]

, 2012
This report aims to provide dietary advice which is based on what is known so far about the effect of a diet, particularly on iron overload in HFE-hemochromatosis.
van Doorn, G.M., Gosselink, I.M.G.
core   +1 more source

Hemochromatosis: an endocrine liver disease.

, 2007
This review acknowledges the recent and dramatic advancement in the field of hemochromatosis and highlights the surprising analogies with a prototypic endocrine disease, diabetes. The term hemochromatosis should refer to a unique clinicopathologic subset
PIETRANGELO, Antonello
core   +1 more source

Arthropathy in juvenile hemochromatosis

, 2003
Objective. To evaluate whether arthropathy is associated with juvenile hemochromatosis and, if so, to assess the relationship between this feature and other clinical features of the disease. Methods.
Papanikolaou, G, Jibreel, I, Vaiopoulos, G, Politou, M, Sakellaropoulos, N, Loukopoulos, D   +5 more
core   +1 more source

The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis

HemaSphere
Hemochromatosis is an inherited iron overload condition caused by mutations that reduce the levels of the iron‐regulatory hormone hepcidin or its binding to ferroportin.
Naja Nyffenegger, Anna Flace, Ahmet Varol, Patrick Altermatt, Cédric Doucerain, Hanna Sundstrom, Franz Dürrenberger, Vania Manolova   +7 more
doaj   +1 more source

Screening for hemochromatosis in Turkey

, 2004
In this study we screened 3060 consecutive blood donors for an unbound iron-binding capacity level of
Gurel, S, Metin, O, Erkan, O, Bozkaya, H, Bozdayi, AM, Bektas, M, Yurdaydin, C, Akay, C, Aslan, O, Uzunalimoglu, O, Ibrahimoglu, D, Akbiyik, F, Dalva, K   +12 more
core   +1 more source

Hemochromatosis and blood donation

, 2017
The voluntary, unpaid, altruistic blood donor is a cornerstone of current transfusion medicine. The complexity of medical and ethical issues related to blood donation and hemochromatosis has led to a large number of studies related to the safety of the ...
Braseth, Turid Aarhus, Hervig, Tor, Røsvik, Anne Synnøve   +2 more
core  

Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis

Haematologica, 2005
BACKGROUND AND OBJECTIVES: The low prevalence of the C282Y mutation of the HFE gene in Japan means that the genetic background of hemochromatosis in Japanese patients remains unclear. In a previous report, we showed that 3 patients from one family had an
C Koyama, S Wakusawa, H Hayashi, R Suzuki, M Yano, K Yoshioka, M Kozuru, Y Takayamam, T Okada, H Mabuchi   +9 more
doaj